Early Severe Inflammatory Responses to Uropathogenic E. coli Predispose to Chronic and Recurrent Urinary Tract Infection by Hannan, Thomas J. et al.
Early Severe Inflammatory Responses to Uropathogenic
E. coli Predispose to Chronic and Recurrent Urinary Tract
Infection
Thomas J. Hannan
1,2, Indira U. Mysorekar
2,3, Chia S. Hung
1, Megan L. Isaacson-Schmid
3, Scott J.
Hultgren
1*
1Department of Molecular Microbiology and Center for Women’s Infectious Disease Research, Washington University School of Medicine, St. Louis, Missouri, United States
of America, 2Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America, 3Department of
Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri, United States of America
Abstract
Chronic infections are an increasing problem due to the aging population and the increase in antibiotic resistant organisms.
Therefore, understanding the host-pathogen interactions that result in chronic infection is of great importance. Here, we
investigate the molecular basis of chronic bacterial cystitis. We establish that introduction of uropathogenic E. coli (UPEC)
into the bladders of C3H mice results in two distinct disease outcomes: resolution of acute infection or development of
chronic cystitis lasting months. The incidence of chronic cystitis is both host strain and infectious dose-dependent. Further,
development of chronic cystitis is preceded by biomarkers of local and systemic acute inflammation at 24 hours post-
infection, including severe pyuria and bladder inflammation with mucosal injury, and a distinct serum cytokine signature
consisting of elevated IL-5, IL-6, G-CSF, and the IL-8 analog KC. Mice deficient in TLR4 signaling or lymphocytes lack these
innate responses and are resistant, to varying degrees, to developing chronic cystitis. Treatment of C3H mice with the
glucocorticoid anti-inflammatory drug dexamethasone prior to UPEC infection also suppresses the development of chronic
cystitis. Finally, individuals with a history of chronic cystitis, lasting at least 14 days, are significantly more susceptible to
redeveloping severe, chronic cystitis upon bacterial challenge. Thus, we have discovered that the development of chronic
cystitis in C3H mice by UPEC is facilitated by severe acute inflammatory responses early in infection, which subsequently are
predisposing to recurrent cystitis, an insidious problem in women. Overall, these results have significant implications for our
understanding of how early host-pathogen interactions at the mucosal surface determines the fate of disease.
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Introduction
Persistent microbial infections are a rapidly expanding problem
because of increased antimicrobial resistance [1]. This trend is
particularly concerning because of the increasingly appreciated
role that chronic infections may play in cancer and chronic
inflammatory diseases [2,3,4]. One key example is that of urinary
tract infections (UTI), which are common, highly recurrent, and
can become chronic [5,6]. Females are disproportionately afflicted
by UTI: 50% of all women will have an episode at some point in
their lifetime, and 20 to 30% will have a recurrence within 3 to 4
months of the acute infection [7]. The high incidence of recurrent
UTI (rUTI) suggests that many individuals do not develop
protective immunity to uropathogens, though the capacity to do
so has been demonstrated in both murine and primate
experimental model systems and a phase 2 clinical vaccine trial
in women [8,9,10]. This failure of adaptive immunity may be
partially explained by host genetic and environmental factors, such
as a maternal history of UTI and childhood exposure to
uropathogens, which appear to play significant roles in determin-
ing susceptibility to rUTI [11,12]. However, the molecular basis
for rUTI and how this may relate to mechanisms of chronic
infection, where adaptive immunity also falls short, are unknown.
Furthermore, while antibiotic therapy has been resoundingly
successful in treating acute UTI, recent increases in the prevalence
of antibiotic-resistant uropathogenic strains in the community
threaten to make chronic UTI common again [5,13,14]. Thus,
understanding the host mechanisms contributing to chronic UTI,
and other chronic bacterial infections of the mucosae, is of critical
importance.
Uropathogenic Escherichia coli (UPEC) are by far the most
common cause of UTI, accounting for 80% of outpatient
infections and 25% of nosocomial infections [15]. During an
acute episode, UPEC adhere to and invade the superficial facet
cells of the urinary mucosal epithelium (urothelium) in a type 1
pili-dependent manner [16,17]. UPEC invasion has been reported
to involve several components of lipid rafts such as caveolin-1, an
integral membrane protein found in the inner leaflet of the lipid
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[19,20]; and microtubules [21]. After invasion, urothelial cells can
expel UPEC via a TLR4-dependent exocytic pathway [22].
Alternatively, if UPEC escape into the cytoplasm, they can rapidly
replicate, and subsequently aggregate into intracellular bacterial
communities (IBC) [23]. Aggregation of UPEC into the biofilm-
like IBC depends upon type 1 pili expression, independent of
urothelial invasion, and is part of a mechanism for bacteria to
evade extracellular host defenses while rapidly expanding in
numbers during acute infection [24]. IBCs are transient in nature.
Upon IBC maturation during approximately the first 12 to
16 hours of infection, the bacteria detach from the biomass and
flux back into the lumen, spreading to neighboring epithelial cells
where they are capable of initiating another IBC [25]. IBC
formation has only been observed in the early acute stages of
infection [25]. However, the ability of UPEC to expand in
numbers via IBC formation has been shown to be a prerequisite
for persistence as mutants that are defective in IBC formation are
highly attenuated and rapidly cleared from the urinary tract [26].
IBC formation has been observed in multiple murine backgrounds
with numerous UPEC strains [27]. Evidence of IBC formation has
also been found in the bladders of mice infected with Klebsiella
pneumoniae and in urine sediments from women with acute cystitis
by UPEC, indicating that this intracellular pathogenic cycle is not
unique to UPEC infection of mice [28,29]. UPEC colonization
and invasion of the urothelium triggers innate host responses,
which are mediated in part by Toll-like receptor 4 (TLR4), a
pattern recognition receptor that responds to certain pathogen-
associated molecular patterns such as lipopolysaccharide
[30,31,32]. These early innate responses include bacterial
expulsion, urothelial exfoliation, and bladder inflammation that
is characterized by the production of the pro-inflammatory
cytokine interleukin 6 (IL-6), granulocyte chemotactic cytokines
such as IL-8, the hormone granulocyte colony stimulating factor
(G-CSF), and the T cell-associated, pro-inflammatory cytokine IL-
17A [17,33,34,35,36,37,38].
In humans, the ultimate outcome of UPEC infection of the
urinary tract ranges from acute, self-limiting infection to
asymptomatic bacteriuria (presence of bacteria in the urine), to
recurrent or chronic UTI [7]. Diminished TLR4 receptor
expression and CXCR1 (IL-8 receptor) signaling have been
associated with increased susceptibility to asymptomatic bacteri-
uria and severe pyelonephritis, respectively, in children, highlight-
ing the importance of the innate immune response in determining
disease outcome [39,40]. However, the host mechanisms that
contribute to acute, recurrent and chronic cystitis in adult women
are poorly understood. While mast cells, cd T cells, and
neutrophils have each been implicated in facilitating clearance of
acute UTI in C57BL/6J mice [34,41,42,43], recent studies have
suggested that the role of neutrophils may be more complex than
previously appreciated, highlighting the need for further studies
[33,44]. Adding to this complexity is the fact that the outcome of
experimental UPEC infection differs substantially between inbred
mouse strains [45]. In C57BL/6J mice, which typically resolve
acute infection and bacteriuria within 7–10 days, a small
intracellular population of bacteria resistant to antibiotic therapy
persists latently for months in the bladder urothelium of these mice
[46,47,48,49]. This quiescent intracellular reservoir (QIR) is
distinct from the IBC as it is comprised of fewer than 15 bacteria
persisting in a membrane bound dormant state [49]. QIRs are
capable of re-emerging from dormancy to cause recurrences of
infection and bacteriuria, and may represent one mechanism for
rUTI in humans [49]. In contrast, some C3H background mouse
strains have been reported to develop chronic UTI for up to 2
weeks post-infection [45,50]. These latter strains may reflect in
part the natural course of UTI in women, as placebo-controlled
studies have demonstrated that a majority of women remain
bacteriuric weeks after an acute UTI if not treated with antibiotics,
despite overall improvement of symptoms [51,52]. Thus, these
murine models of chronic UTI, which are not well understood,
merit further study as they could reveal critical host determinants
of UTI pathogenesis.
In this study, we developed an experimental chronic infection
model to study aspects of the host response that determine disease
outcome. Using a C3H/HeN murine model of cystitis, we
demonstrated that while acute, self-limiting infection occurs in a
subset of mice, another potential outcome of UPEC infection is the
establishment of chronic cystitis lasting months. We discovered
acute biomarkers that are predictive for the development of
chronic cystitis and showed that the development of chronic
cystitis was dependent upon severe acute inflammation. Further-
more, results from challenge infections following antibiotic therapy
indicated that a history of chronic cystitis was a significant risk
factor for subsequent severe and chronic infections. These findings
suggest that a common mechanism may underlie both chronic and
recurrent bacterial infections.
Results
C3H/HeN mice develop chronic cystitis in response to
UPEC infection in an infectious dose-dependent manner
C57BL/6J mice typically resolve acute UPEC UTI by 2 weeks
post-infection (wpi), with sterile urines and kidneys and low level
bladder colonization (,10
4 colony-forming units (cfu) UPEC per
bladder) indicative of a latent QIR population [46]. In contrast,
we previously demonstrated that a large percentage of C3H/HeN
mice have high level bladder colonization (.10
4 cfu UPEC per
bladder) at 2 wpi [29]. However, C3H/HeN mice had not been
previously reported to be susceptible to chronic UTI [32,45]. To
determine whether this finding represented an alternative disease
outcome or merely a high rate of recurrence, we performed
comparative long-term UPEC infection studies investigating the
Author Summary
The natural history of urinary tract infection (UTI) with
uropathogenic E. coli in humans frequently includes
persistent bacterial shedding in the urine for weeks after
the initial infection, despite varying degrees of improve-
ment of symptoms. Although antibiotic treatment has
been very successful in treating UTI, antibiotic resistance is
rising and recurrent infections are a common and costly
problem affecting millions of women. Here, we examine an
experimental mouse model of chronic bladder infection
with uropathogenic E. coli, the most common cause of UTI.
We found that the development of chronic bladder
infection was preceded by severe bladder tissue inflam-
mation that results in injury to the lining of the bladder.
Furthermore, immunodeficient mice that lacked these
acute inflammatory responses were protected from
chronic bladder infection, suggesting that the develop-
ment of chronic bladder infection requires immune-
mediated tissue damage during acute infection. Finally,
we demonstrate that mice with a history of chronic
bladder infection that was subsequently cleared with
antibiotic treatment are highly susceptible to further UTI.
Thus, this study has discovered possible overlap in the
mechanisms underlying the development of chronic and
recurrent UTI.
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mice were infected at 7–8 weeks of age with 10
7 cfu of a
kanamycin-resistant derivative of the UPEC strain UTI89, UTI89
Kan
R, unless otherwise indicated, and then followed by longitu-
dinal urinalysis over 4 wpi. We found that C3H/HeN mice were
significantly more susceptible to developing persistent bacteriuria,
as defined by the recovery of greater than 10
4 cfu UTI89 per ml of
urine at all time points over 4 wpi, compared to C57BL/6J mice
(Table 1; Fig. 1A–B). Urine titers of 10
4 cfu/ml or more had
previously been demonstrated to be a reasonable cutoff for
indicating the presence of urinary tract infection in mice when
assaying free catch urine samples [46]. Increasing the inoculum to
10
8 cfu UTI89 significantly increased the incidence of persistent
bacteriuria in C3H/HeN mice from 21% to 52% (P,0.01,
Fisher’s Exact test), while C57BL/6J mice remained resistant to
persistent bacteriuria (Table 1). Resolution of bacteriuria was not
observed in C3H/HeN mice after 4 wpi in 12 persistently
bacteriuric mice from two independent experiments that were
followed for 6–8 months post-infection (data not shown).
Therefore, in response to UPEC infection a subset of C3H/
HeN mice develop persistent bacteriuria lasting months in an
infectious dose-dependent manner.
Of the C57BL/6J and C3H/HeN mice that resolved
bacteriuria, i.e. their urine titers fell to less than 10
4 cfu UTI89
per ml at least once during the course of infection, 80 of 81 had
bladder bacterial titers ,10
4 cfu at 4 wpi (Table 1; Fig. 1C–D).
The presence of low level bladder bacterial burdens after acute
infection, with urine and kidney titers at or near the limit of
detection, is consistent with a quiescent intracellular reservoir
(QIR) population comprised of bacteria in a dormant state
[48,49]. In contrast, C3H/HeN mice with persistent bacteriuria
had significantly higher bladder and kidney titers at 4 wpi (Table 1;
Table 1. The incidence and severity of chronic UTI among inbred mouse strains.
Mouse
Strain
UTI89 KanR
InoculumCFU
Incidence of
Persistent
BacteriuriaA
% (ratio)
Bladder
Titers Kidney Titers
Persistent
Bacteriuria
A
Resolved
Bacteriuria
B
Persistent
Bacteriuria
A
Resolved
Bacteriuria
B
Bladder Titers
Mean of Log10
values ± SD (n)
PPV
C for
.10
4 Bladder
CFU % (ratio)
Bladder Titers
Mean of Log10
values ± SD (n)
NPV
C for
.10
4 Bladder
CFU % (ratio)
Kidney Titers
Mean of Log10
values ± SD (n)
Kidney Titers
Mean of Log10
values ± SD (n)
C3H/HeN 10
7 21 (17/82)
D 6.461.2 (6){ 100 (6/6) 2.060.6 (27) 100 (27/27) 3.661.7 (6){ 1.360.1 (27)
10
8 52 (35/67)
D 6.161.8 (9){ 89 (8/9) 2.260.7 (6) 100 (6/6) 3.961.6 (9){ 1.761.1 (6)
C57BL/6J 10
7 5 (2/44)*
D 5.3 (1) 100 (1/1) 2.360.9 (34) 97 (33/34) 7.4 (1) 1.961.7 (34)
10
8 7 (1/15)*
D 2.5 (1) 0 (0/1) 2.360.5 (14) 100 (14/14) 6.9 (1) 1.560.7 (14)
C3H/HeOuJ 10
7 92 (22/24)* 6.660.8 (22){ 100 (22/22) 1.860.2 (2) 100 (2/2) 6.161.0 (22){ 1.360.0 (2)
10
8 93 (13/14)
D 7.260.4 (13) 100 (13/13) 5.3 (1) 0 (0/1) 6.761.5 (13) 1.9 (1)
C3H/HeJ 10
7 80 (16/20)*
E 4.362.1 (16) 44 (7/16) 2.760.6 (4) 100 (4/4) 6.061.3 (16){ 3.761.6 (4)
10
8 100 (4/4)
F 6.262.5 (4) 75 (3/4) N/A N/A 6.561.6 (4) N/A
C3H/HeSnJ 10
7 40 (2/5)
D 4.663.3 (2) 50 (1/2) 1.560.2 (3) 100 (3/3) 4.063.4 (2) 1.560.3 (3)
10
8 62 (16/26)
G 7.160.5 (16){ 100 (16/16) 2.660.6 (10) 100 (10/10) 5.760.7 (16){ 1.660.5 (10)
C3HeB/FeJ 10
7 20 (2/10) 6.660.2 (2){ 100 (2/2) 2.360.6 (8) 100 (8/8) 4.160.4 (2){ 1.660.5 (8)
10
8 44 (4/9) 7.060.4 (4){ 100 (4/4) 2.160.6 (5) 100 (5/5) 4.961.0 (4){ 1.460.1 (5)
CBA/J 10
7 20 (2/10) 6.960.3 (2){ 100 (2/2) 2.160.4 (8) 100 (8/8) 5.562.3 (2){ 1.360.0 (8)
10
8 30 (3/10) 7.060.3 (3){ 100 (3/3) 2.761.8 (7) 86 (6/7) 6.960.3 (3) 2.162.2 (7)
DBA/2J 10
7 40 (4/10) 5.362.2 (4){ 75 (3/4) 2.160.5 (6) 100 (6/6) 2.762.3 (4) 1.360.0 (6)
10
8 20 (2/10) 3.261.9 (2) 50 (1/2) 1.760.2 (8) 100 (7/7) 1.360.0 (2) 1.360.0 (8)
BALB/cJ 10
7 0 (0/5)
D N/A N/A 2.561.1 (5) 100 (5/5) N/A 1.360.0 (5)
10
8 0 (0/15)*
D N/A N/A 3.760.3 (15) 87 (13/15) N/A 1.560.6 (15)
129S1/SvImJ 10
7 0 (0/9)
F N/A N/A 1.860.8 (9) 100 (9/9) N/A 1.360.0 (9)
10
8 0 (0/10)*
D N/A N/A 1.860.4 (10) 100 (10/10) N/A 1.360.0 (10)
APersistent Bacteriuria is defined as an individual mouse having greater than 10
4 cfu UTI89 Kan
R per ml of free catch urine at every time point through 4 weeks of
infection.
BResolved Bacteriuria is defined as an individual mouse having less than 10
4 cfu UTI89 Kan
R per ml of free catch urine at least once over 4 weeks of infection.
CHere PPV is the positive predictive value of persistent bacteriuria in predicting the occurrence of bladder titers .10
4 cfu at 4 wpi, NPV is the negative predictive value
of resolved bacteriuria in predicting the occurrence of bladder titers .10
4 cfu at 4 wpi.
D5 mice were infected with wild type UTI89 in initial studies and these data are included in the analysis.
E25 mice infected, 5 mice died by 7 dpi.
F4 mice were infected with wild type UTI89 in initial studies and these data are included in the analysis.
G6 C3H/HeSnJ mice were infected with 10
8 cfu wild type UTI89 in initial studies and these data are included in the analysis.
*Incidence of persistent bacteriuria is significantly different from C3H/HeN mice (P,0.05, two-tailed Mann-Whitney).
{Titers significantly different from those from mice that resolved bacteriuria (P,0.05, two-tailed Mann-Whitney).
Limits of detection are Log10 transformed titers of 1.3-1.6 for bladders and 1.3 for kidneys.
doi:10.1371/journal.ppat.1001042.t001
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kidney titers on average (geometric mean) by 2.9 orders of
magnitude at the 10
7 cfu inoculum, and increasing the inoculum
did not significantly alter this bias towards bladder infection
(p=0.38, Mann-Whitney test). As a result, the development of
persistent bacteriuria had a high positive predictive value (PPV) for
the presence of high titer bladder infection (.10
4 cfu) at 4 wpi
(Table 1). In contrast, persistent bacteriuria in C57BL/6J mice
was rare and when it did occur, severe kidney infection with
abscess formation was a consistent finding in those mice (Table 1,
data not shown).
Gross examination of the urinary tract organs of C3H/HeN
mice at 4 wpi infection with either 10
7 or 10
8 cfu UTI89 (n=58)
revealed that all bladders from mice with persistent bacteriuria
(n=18) were enlarged and rigid compared to the bladders from
mice that resolved bacteriuria (n=40). Gross examination of the
kidneys revealed no differences between disease outcomes, and
kidney abscesses were not observed. Histopathological analysis of
bladder tissue was performed on a random subset of mice (n=17).
Bladders from mice that had resolved bacteriuria (n=9) lacked
any evidence of cystitis (inflammation of the bladder) or noticeable
pathology and the bladder epithelium appeared to be fully
repaired (Fig. 1E). In contrast, abundant bacterial colonization
accompanied by lesions of both acute and chronic inflammation,
as defined by the presence of polymorphonuclear leukocytes
(PMN, also called granulocytes) and mononuclear leukocytes,
respectively, was detected in 7 of 8 bladders examined from mice
with persistent bacteriuria (Fig. 1F). Acute inflammation was most
apparent within the urothelium, with epithelial reactivity and
marked infiltration by PMN that resemble neutrophils and other
CD45
+ cells. The bladder urothelium of persistently bacteriuric
mice was hyperplastic and poorly differentiated, lacking the
superficial facet cell layer as indicated by diminished uroplakin III
expression on the luminal surface (Fig. 1G–H). Unlike the acute
phase when UPEC progress through IBCs, bacterial colonization
in these bladders appeared to be entirely luminal in nature as IBCs
or other intracellular bacteria were not observed within the
urothelium by immunofluorescence staining. Chronic inflamma-
tion was observed in the lamina propria (connective tissue layer
underlying urothelium) with accumulations of lymphoid-like
CD45
+ cells in large follicle-like aggregates (Fig. 1F, I–J). These
lymphoid follicles were found in all mice with persistent
bacteriuria (n=8 mice, 2–5 follicles/tissue section), while none
were observed in the bladders of mice that resolved bacteriuria.
Similar pathology of bacterial colonization coupled with both
acute and chronic inflammation were observed in the upper
urinary tract of mice with persistent bacteriuria (data not shown,
n=4). However, these lesions were confined to tissues lined by
urothelium: the ureters and renal pelvices, and were minimal or
absent in the renal medullae and cortices. Thus, persistent
bacteriuria in C3H/HeN mice through 4 wpi is highly indicative
of chronic infection and inflammation of all urothelium-lined
tissues and will be used in the following analyses as a method for
identifying C3H/HeN mice with chronic cystitis.
C3H/HeOuJ and C3H/HeJ mice differ in their
susceptibility to chronic cystitis
The outcome of UPEC infection in C3H/HeOuJ and C3H/
HeJ mice was also investigated, as these two C3H substrains have
been reported to be highly susceptible to chronic bladder and
kidney infection at 2 wpi with UPEC [45,46]. We found that both
C3H/HeOuJ and C3H/HeJ mice develop persistent bacteriuria
at a much more efficient rate than C3H/HeN mice upon infection
with 10
7 cfu UTI89 Kan
R (Table 1, Fig. 2A). However,
unexpectedly we found that C3H/HeJ mice, which are incompe-
tent for TLR4 signaling, had significantly lower levels of bladder
infection compared to C3H/HeOuJ mice at 4 wpi (Fig. 2B;
Table 1). Yet, these strains were equally and highly susceptible to
pyelonephritis compared to C3H/HeN mice (Fig. 2C, Table 1),
often with grossly visible kidney abscess formation. Thus,
persistent bacteriuria is a poor predictor of high bladder bacterial
burdens (.10
4 cfu) at 4 wpi in C3H/HeJ mice compared to either
C3H/HeN or C3H/HeOuJ mice at 10
7 cfu inoculum (PPV of
44% versus 100%, P,0.05, Fisher’s Exact Test; Table 1). Finally,
5/25 C3H/HeJ mice died between 1 and 7 days post-infection
(dpi), demonstrating the contribution of TLR4 signaling in
preventing fatal bacterial infection.
Among C3H/HeOuJ and C3H/HeJ mice with persistent
bacteriuria and high bladder bacterial burdens (.10
4 cfu) at 4
wpi, a number of differences were observed. The bladders from
C3H/HeJ mice meeting these criteria (n=7) weighed significantly
less than those from C3H/HeOuJ mice (n=22) (Fig. 2D). The
bladders from C3H/HeOuJ mice with persistent bacteriuria
demonstrated lesions of acute and chronic bladder inflammation
(Fig. 3, panels A, and D) identical to those described above for
C3H/HeN mice with persistent bacteriuria (see Fig. 1). These
included marked luminal bacterial colonization and urothelial
hyperplasia accompanied by extensive acute and chronic inflam-
matory cell infiltrates, highlighted by marked PMN infiltration and
numerous lymphoid follicles. In contrast, histological evidence of
bladder inflammation was only present in the 5 C3H/HeJ mice
with the highest bladder bacterial burdens (.10
6 cfu). Moreover,
this inflammation, when present, was greatly subdued (Fig. 3,
panels B, and E) compared to that observed in C3H/HeOuJ and
C3H/HeN mice with high bladder bacterial burdens. Specifically,
neutrophil infiltration from the mucosal tissue was reduced and
lymphoid follicles were absent. For comparison, C3H/HeOuJ
mice that resolved bacteriuria and C3H/HeJ mice with bladder
colonization below 10
6 cfu all lacked detectable bladder
inflammation (Fig. 3, panels C and F, data not shown).
Figure 1. C3H/HeN mice develop chronic cystitis in response to UPEC infection in an infectious dose-dependent manner. A–B,
Representative urine bacterial titer time course over 4 wpi with 10
7 cfu UTI89 Kan
R in A, C57BL/6J and B, C3H/HeN mice. Solid lines connect the urine
titers over time for each individual mouse. Dashed horizontal line represents the cutoff for significant bacteriuria in free catch urines: 10
4 cfu/ml. C–D,
Urine (U), bladder (B) and kidney (K) titers of C, C57BL/6J and D, C3H/HeN mice at 4 wpi with 10
7 or 10
8 cfu UTI89 Kan
R or UTI89, grouped by
outcome: resolved bacteriuria (Resolved) or persistent bacteriuria (PB). Solid lines connect the different urine and tissue titers from the same mouse.
Dotted horizontal lines show the limits of detection. E–H, Paraffin-embedded bladder sections 4 wpi with UTI89 Kan
R were examined by E–F,
Hematoxylin & eosin (H&E) staining and light microscopy, or G–H, indirect immunofluorescence (IF) microscopy, staining with antibodies against E.
coli (green) and uroplakin III (red); nuclei are counterstained with bis-benzimide (blue). Bladder sections from mice that resolved bacteriuria are
displayed in panels E and G; from persistently bacteriuric mice in panels F and H. In panel H, arrows indicate luminal clusters of bacteria associated
with immune and exfoliated urothelial cells. I–J, Frozen sections of the bladder of a persistently bacteriuric C3H/HeN mouse at 7.5 months post-
infection with UTI89 were examined: I, H&E stained section of the trigone region (area of bladder near urethra where ureters enter), J, IF micrograph
of a serial section of I, staining for CD45 (red) and the FimH adhesin of E. coli (green); nuclei are counterstained with bis-benzimide (blue). In panels E–
J, bars approximate 50mm, ‘‘L’’ indicates bladder lumen, and dashed line denotes the approximate location of the urothelial basement membrane.
doi:10.1371/journal.ppat.1001042.g001
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the bladder also differed between C3H/HeOuJ and C3H/HeJ
mice. As with C3H/HeN mice, the terminal differentiated facet cell
layer was entirely ablated in the C3H/HeOuJ mice with persistent
bacteriuria and high titer bladder infections as indicated by the lack
of uroplakin staining (Fig. 3G). In contrast, in the C3H/HeJ mice
with persistent bacteriuria, high bladder titers, and evidence of
bladder inflammation, the bladder mucosae retained a capacity for
terminal differentiation, albeit reduced, as evidenced by the
intermediate level of uroplakin expression compared to C3H/HeJ
mice that lacked bladder inflammation (Fig. 3H and I). Further-
more, fully mature superficial facet cells with abundant uroplakin
expression were detected in every bladder section, and a number of
these harbored dense bacterial colonies surrounded by uroplakin
staining, i.e. apparent IBCs (Fig. 3H, arrow). Neither mature
superficial facet cells, nor IBCs were ever observed in the chronic
stages of UTI in C3H/HeN or C3H/HeOuJ mice although IBCs
were observed normally in the acute stages. We also observed that
luminal colonization of the urothelium appeared much more robust
in these 5 C3H/HeJ mice than in the other two C3H substrains,
resembling biofilms (Fig. 3, panels E & H).
Therefore, in contrast to previous studies [45,50], our data
indicate that C3H/HeJ mice have significantly lower bladder
bacterial burdens during chronic infection than C3H/HeOuJ
mice, despite similar bacterial burdens in the kidneys. Further-
more, when bacterial persistence does occur in the bladders of
C3H/HeJ mice, it may be mechanistically distinct from chronic
cystitis in TLR4 signaling-competent C3H mice. Given that C3H/
HeJ mice are known to be immunodeficient, mounting only very
muted acute inflammatory responses to UPEC infection [30,53],
these results suggest that the host immune response may
contribute to the development of chronic cystitis.
Chronic cystitis is a common response in multiple, but
not all, murine backgrounds to UPEC and Klebsiella
pneumoniae infection of the urinary tract
We then investigated whether chronic cystitis was specific to
UPEC infection in C3H/HeN and C3H/HeOuJ mice. We found
that other C3H sub-strains, C3H/HeSnJ and C3HeB/FeJ, were also
capable of developing chronic cystitis in response to infection with
UTI89 (Table 1, Fig. S1A–B). However, the relative susceptibilities of
these sub-strains to chronic cystitis differed: C3H/HeN mice were
a m o n gt h em o s tr e s i s t a n t( 1 8 %a t1 0
7 cfu) and C3H/HeOuJ mice
were the most susceptible (92% at 10
7 cfu). CBA/J mice, which are
commonlyused in experimentalUTImodels[54] and likeC3H mice
are descendents of a DBA by Bagg albino cross, and DBA/2J mice
wereeach also susceptibletochronic cystitis (Table1, Fig. S1C–D). In
contrast, other common strains such as BALB/cJ and 129S1/SvImJ
were not observed to develop chronic cystitis at either 10
7 or 10
8 cfu
inoculum of UTI89 in this model (Table 1, Fig. S2), despite successful
acute infections. Conversely, infection of C3H/HeN mice with either
J96, another UPEC isolate, or Top52, a Klebsiella pneumoniae human
cystitis isolate that had previously been demonstrated to form IBCs
during acute infection [29], resulted in varying incidences of chronic
Figure 2. The outcome of UPEC infection of the urinary bladder differs between C3H/HeOuJ and C3H/HeJ mice. C3H/HeOuJ (closed
circles) or C3H/HeJ (open circles) mice were infected with 10
7 cfu UTI89 Kan
R and followed for 4 wpi. Data were compiled from two independent
experiments. A, Urine bacterial titers were assayed over 4 wpi. Solid lines connect the urine titers over time for each individual mouse. Dashed
horizontal line represents the cutoff for significant bacteriuria in free catch urines: 10
4 cfu/ml. B–C, B, Bladder and C, Kidney titers were assayed at 4
wpi; D, Bladders with high bacterial burdens (.10
4 cfu from panel B) were weighed at 4 wpi. All statistics in panels B, C, and D are the results of a two-
tailed Mann-Whitney U test: **, P,0.01, ***, P,0.001 and ns, not significant; horizontal bars indicate median values.
doi:10.1371/journal.ppat.1001042.g002
Early Inflammation Facilitates Chronic Cystitis
PLoS Pathogens | www.plospathogens.org 6 August 2010 | Volume 6 | Issue 8 | e1001042cystitis (Fig. S3). Therefore, chronic cystitis in response to UPEC or
Klebsiella pneumoniae infection appears to be restricted to certain strain
backgrounds.
Chronic cystitis can be predicted early in acute infection
by serum cytokine biomarkers that correlate with the
presence of urothelial injury
The relative resistance of TLR4 signaling-deficient C3H/HeJ
mice, which have muted acute inflammatory responses [45,50,55],
to chronic cystitis when compared to C3H/HeOuJ mice, which
have very robust acute inflammatory responses to UPEC infection
[45,50], suggested a positive association between acute inflamma-
tion and chronic cystitis. To investigate this further, we tested
whether the severity of the acute bladder inflammatory responses
correlated with disease outcome in C3H/HeN mice. We found
that mice that proceeded to develop persistent bacteriuria had
significantly higher urine bacterial titers at 24 hours post-infection
(hpi) than their cage mates that resolved bacteriuria (Fig. 4A).
These mice also had increased numbers of PMN in the urine
(pyuria), and greater weight loss at 24 hours post-infection (hpi)
than their cage mates that resolved bacteriuria (Fig. 4B–C).
However, this weight loss was transient and the mice quickly
recovered to gain weight due to aging, indicating that chronic
infection is well tolerated through 4 wpi. Severe acute pyuria and
weight loss at 24 hpi was also predictive of chronic cystitis in C3H/
HeOuJ mice, but was not observed in C3H/HeJ mice (Fig. S4A–
B). To identify the nature of this acute systemic inflammatory
response, we monitored the serum of mice at 24 hpi by multiplex
cytometric bead array for the presence of 23 mouse cytokines. We
found that C3H/HeN mice that developed persistent bacteriuria
had significantly elevated levels of four serum cytokines at 24 hpi
compared to both mock-infected mice and mice that resolved
Figure 3. Chronic bladder infection in C3H/HeJ mice is histologically distinct from chronic cystitis in C3H/HeOuJ mice. Representative
paraffin-embedded, fixed bladder sections from C3H/HeOuJ mice with chronic cystitis (22 out of 24 mice; panels A, D, & G), C3H/HeJ mice with high
bacterial burdens and evidence of bladder inflammation (5 out of 20 mice; panels B, E, & H), and the remaining C3H/HeJ mice that uniformly lacked
evidence of bladder inflammation (15 out of 20 mice; panels C, F, & I) were analyzed at 4 wpi; Bars approximate 50 mm in length. A–F, Sections were
stained with hematoxylin & eosin and examined by light microscopy; boxes in panels A–C demarcate boundaries of higher magnification images in
panels D–F. G–I, Sections were analyzed by indirect immunofluorescence (IF) microscopy, staining for E. coli (green) and uroplakin III (red), with nuclei
counterstained with bis-benzimide (blue). ‘‘L’’ denotes bladder lumen; dashed line indicates approximate location of basement membrane;
arrowheads point to urothelial surface bacterial colonization in panel E; and the white arrow points to a mature superficial facet cell containing a
possible IBC in panel H.
doi:10.1371/journal.ppat.1001042.g003
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(G-CSF, encoded by Csf3), and keratinocyte-derived cytokine
(KC, a.k.a. growth-regulated alpha protein, encoded by Cxcl1), an
IL-8 analog in mice (Fig. 4D). Elevated levels of these serum
cytokines at 24 hpi were also prognostic of chronic cystitis in
C3H/HeOuJ, but not C3H/HeJ, mice (Fig. S4C). Another UPEC
isolate, J96, also elicited similar serum responses prognostic of
chronic cystitis in C3H/HeN mice (Fig. S5). Finally, we found that
elevated urine IL-6, G-CSF, and KC, but not IL-5, were also
predictive of the development of chronic cystitis in C3H/HeN
mice at 24 hpi (Fig. S6)
At 24 hpi, the bladder inflammatory responses to acute UPEC
infection vary widely among individual C3H/HeN mice infected
with 10
7 cfu UTI89 (Fig. 5A–D), despite the fact that the bacterial
titers recovered from these bladders are fairly uniform at 6 hpi
[24,29]. Thus, we investigated the potential correlation between
the severity of bladder inflammation and serum cytokine levels as
prognosticators of chronic cystitis. C3H/HeN mice were infected
with 10
7 cfu UTI89. At 24 hpi we found that 20% of the mice had
severely inflamed urinary bladders with full-thickness urothelial
necrosis (inflammatory scores of 5), marked edema, epithelial
necrosis, and inflammatory cell infiltrates (Fig. 5A, 5B (right) and
5D), while the other 80% of the bladders had minimal to moderate
inflammation at 24 hpi (Fig. 5A, inflammatory scores of 1–4; 5B
(left) and 5C). The incidence of severe inflammation was infectious
dose-dependent, as 80% of mice had bladder inflammatory scores
of 5 when infected with 10
8 cfu (Fig. 5A). The levels of all four
serum cytokines prognostic of chronic cystitis strongly and
positively correlated with the degree of bladder inflammation at
24 hpi with 10
7 cfu (Fig. 5E). Collectively, these findings
demonstrate a strong association between severe, acute immuno-
pathology and the development of chronic cystitis.
C3H background severe combined immunodeficient
mice are resistant to developing chronic cystitis
To further substantiate whether the immune response is
required for the development of chronic cystitis in C3H mice,
we investigated the outcome of UPEC infection in C3H
background severe combined immunodeficient (C3Hscid) mice,
which lack mature lymphocytes and may have other immune
Figure 4. C3H/HeN mice that develop chronic cystitis can be distinguished from their cage mates by several parameters of infection
and host response at 24 hpi. A–C, Parameters of acute infection and inflammation were assayed in mice that either resolved bacteriuria (R, open
circles) or developed persistent bacteriuria (PB, open triangles). A, Urine bacterial titers were assayed at 24 hpi with 10
7 cfu of UTI89 Kan
R or UTI89;
data is compiled from seven independent experiments (n=92 mice). B, Urine sediments at 24 hpi with either 10
7 or 10
8 cfu of UTI89 Kan
R or UTI89
were analyzed and assigned a semi-quantitative polymorphonuclear cell (PMN) score from 0–4 as explained in the Materials and Methods; data is
compiled from 6 independent experiments (n=123 mice). C, Mice were weighed at every urine collection time point in most studies. Plot depicts the
weight loss or gain at 1 and 28 days post-infection (dpi) with 10
8 cfu UTI89 Kan
R; data is compiled from two independent experiments (n=42 mice).
D, Mouse sera collected at 24 hpi with either PBS (Mock) or 10
8 cfu UTI89 Kan
R infected mice were analyzed for the presence of 23 cytokines by
cytometric bead array as described in the Materials and Methods. UPEC infected mice were then grouped by disease outcome: resolved bacteriuria
(Resolved), or persistently bacteriuric (PB). These four cytokines were significantly elevated in PB mice in each of three independent experiments;
data shown is from one representative experiment. All statistics are by Mann-Whitney U two-tailed test: *, P,0.05, **, P,0.01, ***, P,0.001 and ns,
not significant; horizontal bars indicate median values.
doi:10.1371/journal.ppat.1001042.g004
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PLoS Pathogens | www.plospathogens.org 8 August 2010 | Volume 6 | Issue 8 | e1001042Figure 5. C3H/HeN mice that develop chronic cystitis have severe bladder inflammation at 24 hpi. Individual C3H/HeN mice were
infected with either 10
7 or 10
8 cfu of UTI89 and bladders and sera collected at 24 hpi in two independent experiments. Data shown are from one
representative experiment. A, Paraffin-embedded, fixed bladder sections were stained with hematoxylin & eosin and examined by light microscopy.
Sections were scored from 0–5 to quantify the severity of inflammatory lesions as explained in the Materials and Methods; horizontal bars indicate
median values. B, Examples are shown of the disparate response to UPEC infection in two individual mice from the same cage, infected on the same
day with the same inoculum (10
7 cfu UTI89). C–D, Higher magnification images of the two bladders shown in panel B. Inflammatory scores were 3 and
5 for panels C and D, respectively. Bars approximate 50 mm in length. E, Scatter plot analysis of serum IL-5, IL-6, G-CSF, and KC values, as labeled,
versus the inflammatory scores of the bladders from the same individual mice. Significance (P) and strength (r) of correlations shown were
determined by Spearman’s rank correlation test.
doi:10.1371/journal.ppat.1001042.g005
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entirely resistant to the development of chronic cystitis
compared to the congenic wild type strain, C3H/HeSnJ
(Figs. 6A, S7A). Even after infection with 10
8 cfu of UTI89,
only 4% of C3Hscid mice developed persistent bacteriuria and
high titer (.10
4 cfu) bladder infection at 4 wpi, compared to
62% of C3H/HeSnJ mice (1/23 versus 16/26, P,0.0001,
Fisher’s Exact test). However, intermittent bacteriuria was
common in the C3Hscid mice, perhaps indicating a failure to
eliminate colonization of specific niches. Nevertheless, intermit-
tent bacteriuria was not associated with bladder bacterial
burdens .10
4 cfu at 4 wpi.
Figure 6. C3H background severe combined immunodeficient mice have muted acute inflammatory responses to UPEC infection and
are resistant to chronic cystitis. C3H/HeSnJ (closed circles)or C3SnSmn.CB17-Prkcscid/J (C3Hscid, open circles) mice were infected with 10
8 cfu of UTI89
Kan
Ror UTI89. A,Urineandtissuetiterswereassayedat4wpi;solidlinesconnectthedifferenturineandtissuetitersfromthesamemouse.B, PMN scores of
the urine sediments were determined at 24 hpi. The data shown in panels A and B were compiled from four independent experiments. C,S e r aw e r e
collected for cytokine analysis at 24 hpi. Data are representative of two independent experiments. All statistics in panels B–C are the results of the Mann-
Whitney U test: **, P,0.01, ***, P,0.001 and ns, not significant, horizontal bars indicate median values. D–E, Representative paraffin-embedded, fixed
bladder sections from D, C3H/HeSnJ, and E,C 3 H scid mice, at 24 hpi were stained with hematoxylin & eosin and examined by light microscopy. Asterisks
indicate areas of submucosal edema, arrows indicate apparent IBCs, and bars approximate 50 mmi nl e n g t h .
doi:10.1371/journal.ppat.1001042.g006
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compared to their congenic wild type controls. PMN scores and
weight loss at 24 hpi were significantly reduced (P,0.01 for each,
Mann-Whitney test; Figs. 6B, S7B). Furthermore, while the
C3Hscid mice had a serum IL-5 response similar to wild type
controls, they were completely unable to mount serum IL-6, G-
CSF, and KC responses (Fig. 6C). Examination of the bladder
tissue from 5 C3Hscid and 5 wild type control mice at 24 hpi
(Fig. 6D–E) revealed that these strains had similar levels of bladder
edema (Fig. 6E). However, C3Hscid mice entirely lacked the severe
Figure 7. C3H mice treated with the glucocorticoid anti-inflammatory drug, dexamethasone, just prior to infection have muted
acute inflammatory responses to UPEC infection and are protected against chronic cystitis. C3H/HeN mice were treated with either
saline (closed circles) or 200 mg dexamethasone sodium phosphate (open circles) two hours prior to infection with 10
8 cfu UTI89 Kan
R. A, urine (U),
bladder (B) and kidney (K) titers were determined at 4 wpi; solid lines connect the different urine and tissue titers from the same mouse. B, PMN
scores of the urine sediments were determined 24 hpi. A–B, Data are compiled from three independent experiments. C, Percent weight change at 24
hpi was determined. D, Serum cytokine analysis of mice at 24 hpi with 10
8 cfu of UTI89 Kan
R is depicted. C–D, Data are compiled from four
independent experiments. E–G, C3H/HeN mice pre-treated with either saline or dexamethasone were sacrificed at 24 hpi and paraffin-embedded,
fixed bladder sections were stained with hematoxylin & eosin and examined by light microscopy. Semi-quantative bladder inflammatory scores are
plotted in panel E, and representative images of bladders from mice treated with F, saline, and G, dexamethasone, are depicted; arrowheads indicate
apparent IBCs; bars approximate 50 mm in length. All statistics in panels B–E are the results of the Mann-Whitney U test: *, P,0.05, **, P,0.01, and
***, P,0.001; horizontal bars indicate median values.
doi:10.1371/journal.ppat.1001042.g007
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PLoS Pathogens | www.plospathogens.org 11 August 2010 | Volume 6 | Issue 8 | e1001042Figure 8. C3H/HeN mice with a history of chronic cystitis are more susceptible to chronic cystitis upon challenge infection. A–D, Mice
were infected with 10
7 UTI89 Kan
R or mock-infected with PBS and followed for 4 wpi by longitudinal urinalysis in two independent experiments. All
mice were treated with antibiotics at 4 wpi and sacrificed 4 weeks after initiation of antibiotic therapy. Paraffin-embedded, fixed bladder sections
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wild type C3H mice at 24 hpi, despite vigorous acute infection,
including numerous apparent IBCs (Fig. 6E, arrows). Thus, the
muted inflammatory response does not appear to result from a
defect in acute colonization. These data provide further evidence
that inflammation is required for the development of chronic
cystitis and suggest that lymphocytes may play a necessary role in
this process.
The development of chronic bacterial cystitis in C3H/HeN
mice is dependent upon severe acute inflammatory
responses
To test whether severe acute inflammation is specifically required
for the development of chronic cystitis, we treated C3H/HeN mice
with a single immunosuppressive dose of the glucocorticoid,
dexamethasone sodium phosphate, by intraperitoneal injection
2 hours prior to infection. We found that mice treated with
dexamethasone were significantly more resistant to the development
of chronic cystitis (Figs. 7A, S8A) upon infection with 10
8 cfu UTI89
Kan
R compared to saline-treated controls (2/17 versus 13/18,
p,0.001, Fisher’s Exact test). Furthermore, dexamethasone treat-
ment significantly reduced the severity of acute inflammation at 24
hpi in reponse to UPEC infection as indicated by pyuria (Fig. 7B),
weight loss (Fig. 7C), serum cytokines (Fig. 7D), and bladder
inflammation (Fig. 7E–G). Yet, these groups had similar bladder
bacterial burdens at 24 hpi (Fig. S8B), including what appears to be
robust IBC formation in the dexamethasone treated group (Fig. 7G,
arrows). Thus, the development of chronic cystitis appears to require
severe acute inflammation, strongly suggesting that bladder immu-
nopathology during acute infection facilitates the establishment of
chronic infection.
The development of chronic bacterial cystitis in juvenile
C3H/HeN mice predisposes them to chronic infection
upon subsequent challenge with UPEC
Lymphoid follicles have been reported in humans with
persistent bacteriuria, with or without symptoms of UTI, and
have been reported to resolve spontaneously after antibiotic
therapy to clear infection [56,57]. We also found that persistent
bacteriuria in C3H/HeN mice was rapidly eliminated by
antibiotic therapy initiated at 4 wpi (n=46). Bladder tissue
sections from a sample of these mice (n=5), together with
mock-infected controls (n=6) and mice that had resolved
bacteriuria (n=9), were examined one month after initiation of
antibiotic therapy. This analyisis revealed that urothelial
integrity was indistinguishable between these groups, indicating
full healing of the urothelium in the previously infected mice
(Fig. 8A–C). However, the bladders of mice with a history of
persistent bacteriuria weighed significantly more than either of
the other two groups (Fig. 8D), and while the lymphoid follicles
were largely gone, small to moderately sized clusters of
mononuclear cells remained in the bladder lamina propria
(Fig. 8C). Similar chronic inflammatory cell infiltrates have
been reported after serial UPEC infections of C57BL/6J mice,
where their presence coincides with the development of
adaptive immunity [9].
These findings suggested that an acquired, bladder-resident
immune cell population may modulate the host response to
subsequent infection. Therefore, we tested whether the specific
disease outcome, persistent bacteriuria or resolved bacteriuria,
affected the susceptibility of mice to UTI challenge after
clearance of infection with antibiotics, compared to age-
matched naı ¨ve mice (Fig. 8D). All challenges were performed
4 weeks after initiation of antibiotic therapy, which allowed time
for the bladder urothelium to heal fully as described above
(Fig. 8A–C). We found that mice with a history of persistent
bacteriuria for 4 wpi with UTI89 Kan
R at 7–8 weeks of age
were significantly more prone to developing persistent bacteri-
uria (Fig. 8E) and chronic cystitis (Table 2) upon challenge
infection with an isogenic, spectinomycin-resistant UTI89
strain, UTI89 Spc
R, at 15–16 weeks of age than either their
cage mates who spontaneously resolved bacteriuria or age-
matched naı ¨ve mice that had previously been mock-infected.
Table 2. Incidence of chronic cystitis upon challenge
infection.
Outcome of Initial
InfectionA
Duration of Initial Infection Prior to
Antibiotic Therapy
28 days 14 days 1 day
A
Mock-Infected 1/24 2/25 4/20
4% 8% 20%
Resolved Bacteriuria 0/16 0/30 0/21*
0% 0% 0%
Persistent Bacteriuria 6/15{ 7/20{{ 1/21
40% 35% 6%
AFor mice infected only one day, individuals with serum KC values below the
median value at 24 hpi were assigned to the Resolved Bacteriuria group and
those with serum KC values above the median value at 24 hpi were assigned
to the Persistent Bacteriuria group.
{p,0.01 compared to both Mock-Infected and Resolved Bacteriuria groups,
Fisher’s Exact test.
{{p,0.001 compared to Resolved Bacteriuria group, Fisher’s Exact test.
*p,0.05 compared to Mock-Infected group, Fisher’s Exact test.
doi:10.1371/journal.ppat.1001042.t002
were stained with hematoxylin & eosin and examined by light microscopy. Representative images of mice that A, were mock-infected, B, had resolved
bacteriuria, or C, had persistent bacteriuria are shown; bars approximate 50 mm in length. Statistics are the results of the Mann-Whitney U test:
**, P,0.01, and ***, P,0.001. D, Bladders were weighed at sacrifice; horizontal bars indicate median values. E, Experimental time line for panel F:
mice were followed by longitudinal urinalysis (each urine collection is indicated by small arrow) for the entire experiment to identify persistently
bacteriuric mice prior to antibiotic therapy and after re-infection, and to confirm clearance of bacteriuria with antibiotic therapy. F–H, Combined time
courses from two independent experiments each are displayed, charting the UTI89 Spc
R urine bacterial titers during the 4 weeks after challenge
infection, when antibiotic therapy was initiated at F, 28 days, G, 14 days, or G, 1 day after the initial infection. In all cases, mice were challenged 4
weeks after the initiation of antibiotic therapy. For panels F and G, mice are grouped by the outcome of urinalysis during the initial infection: Mock,
mock-infected with PBS at week 0; Resolved Bacteriuria, infected with UTI89 Kan
R at week 0 and subsequently had at least one time point with
,10
4 cfu/ml UTI89 Kan
R;o rPersistent Bacteriuria, infected with UTI89 Kan
R at week 0 and had .10
4 cfu/ml UTI89 Kan
R for each time point. For
panel H, mice are grouped by serum KC value at 24 hpi with UPEC: Mock, mock-infected with PBS at week 0; Resolved Bacteriuria, infected with
UTI89 Kan
R at week 0 and have serum KC in the lower 50% of values at 24 hpi; or Persistent Bacteriuria, infected with UTI89 Kan
R at week 0 and
had serum KC in the upper 50% of values at 24 hpi. Solid lines connect the urine titers over time for each individual mouse. Horizontal dashed lines
represent the cutoff for significant bacteriuria in free catch urines: 10
4 cfu/ml.
doi:10.1371/journal.ppat.1001042.g008
Early Inflammation Facilitates Chronic Cystitis
PLoS Pathogens | www.plospathogens.org 13 August 2010 | Volume 6 | Issue 8 | e1001042Redevelopment of chronic cystitis was significantly associated
with the onset of severe pyuria and elevated serum IL-5, G-CSF,
and KC at 24 hpi, compared to mice that resolved the challenge
infection, whether or not they had a history of chronic cystitis
(data not shown). The rapid clearance of bacteriuria after
bacterial challenge in mice that had previously spontaneously
resolved infection, compared to naı ¨ve mice, suggests that these
mice develop some degree of acquired immunity to UPEC.
Only 5% (2/42) of mice previously infected with UTI89 Kan
R
had recurrent bacteriuria with this strain on the day of
challenge, 4 weeks after initiation of antibiotic therapy, similar
to what was previously reported in C57BL/6J mice [46].
Otherwise, little reemergence of UTI89 Kan
R was observed
upon challenge with UTI89 Spc
R (data not shown). As
additional controls, a subset of 20 mice, 10 previously infected
and 10 age-matched naı ¨ve, and all treated with the antibiotic
regimen described above, were challenged with PBS and their
urines remained free of UPEC for the remainder of the
experiment (data not shown).
To determine the duration of infection sufficient for modulat-
ing the host susceptibility to further infection, we initiated
antibiotic treatment at 24 hpi and 2 wpi and then challenged
mice with UPEC four weeks later, as described above (Table 2,
Fig. 8F–G). We found that 14 days of chronic infection were
sufficient for inducing the hypersusceptibility phenotype to
challenge infection, but 1 day of infection was not. This result
indicates that, although accurate indicators of the development of
chronic cystitis exist at 24 hpi, infection-related events in the
course of sub-acute to chronic UTI are necessary for the
enhanced susceptibility to further chronic infections. Further-
more, these findings refute the alternative explanation to our
data: that we are selecting for a pre-existing subpopulation, either
due to the presence of genetic polymorphisms within the breeding
colony, or prior exposure to pathogens. Taken together, these
data indicate that the development of chronic UPEC cystitis
predisposes C3H mice to chronic UTI upon subsequent
colonization.
Discussion
Using a C3H murine model of UTI, we have unveiled an
inflammation-dependent checkpoint occurring at the host-patho-
gen interface within the first 24 hours of infection that has
significant ramifications upon the long term fate of disease.
Furthermore, subsequent development of chronic cystitis alters the
host susceptibility to further bacterial cystitis after antibiotic
therapy, resulting in increased susceptibilities to both severe acute
symptomatology and chronic infections. We identified elevated IL-
5, IL-6, G-CSF, and KC as a serum biomarker signature
prognostic of the development of chronic cystitis in C3H mice.
This signature was accompanied by severe bladder inflammation
at 24 hpi as indicated by marked bladder edema and pyuria. While
the severity of bladder damage and systemic signs diminish after
the early acute stage of infection, these mice remain persistently
bacteriuric and develop chronic cystitis. This improvement in
clinical signs despite persistent bacteriuria is similar to the natural
course of UTI reported in a majority of women from placebo-
controlled studies [51,52]. The alternate host response was
characterized by mild to moderate bladder inflammation in the
acute stage with minimal or no systemic signs. These mice
typically achieved resolution of acute bacteriuria within 1–2 weeks,
though recurrent bacteriuria after this time was common, either
because of transient periurethral colonization or rUTI. The fate of
disease outcome appears to be determined within the first 24 hpi
and is infectious dose-dependent, indicating that this response is at
least partially stochastic. Understanding the molecular and cellular
mechanisms of this acute checkpoint may have far-reaching
implications for how UTI and other chronic and recurrent
infections are treated and evaluated.
Our findings indicate that a glucocorticoid-sensitive, pro-
inflammatory response to early acute infection is required for
the efficient development of chronic cystitis. Glucocorticoids are
made in the adrenal gland and, among other functions, act as
potent anti-inflammatory agents. Specifically, they block the
production of acute mediators of inflammation such as TNFa,
IL-1, IL-6, and arachidonic acid derivatives such as prostaglandins
and leukotrienes, in part through blockade of NF-kB activity [58].
For example, dexamethasone is commonly used as an adjunct
therapy to treat acute bacterial meningitis, as its anti-inflammatory
activity appears to improve survival [59]. The immunosuppressive
effects of a single dexamethasone treatment are transient,
providing evidence for a mucosal immune checkpoint early in
UPEC infection that, when triggered, leads to urinary tract
immunopathology and facilitates chronic cystitis.
The resistance of C3Hscid mice to chronic cystitis implicates
lymphocytes as immune cells necessary for the development of
chronic cystitis in C3H mice. Specifically, our data suggest that
one or more lymphocyte populations with innate properties may
play a necessary role in mediating a number of the early severe
inflammatory responses to UPEC that are associated with the
development of chronic cystitis. Candidate lymphocytes include cd
T cells, natural killer T (NKT) cells, and B1 cells, which make
natural antibodies. cd T cells have previously been implicated in
host resistance to UTI in C57BL/6J mouse infection models
[34,41], and they are normally found in the bladder lamina
propria of naı ¨ve mice [60]. Acute host responses that were muted
or absent in C3Hscid mice included severe pyuria, weight loss, and
elevation of serum IL-6, G-CSF, and KC. Induction of both IL-6,
an acute phase pro-inflammatory cytokine that causes fever and
malaise if systemic, and IL-8, a chemotactic cytokine for
granulocytes, are strongly associated with UTI in both humans
and mice [36,37,61,62,63]. The combination of elevated IL-6,
KC, an IL-8 analog, and G-CSF, a growth factor that promotes
granulocyte development and release from the bone marrow, in
both the serum and urine would explain the weight loss and severe
acute PMN response associated with the development of chronic
cystitis in mice [64]. Yet, these acute molecular and cellular
responses are inadequate for resolving infection in C3H mice.
Furthermore, a recent study suggests that such a response may
contribute to disease pathogenesis, as depletion of G-CSF
surprisingly resulted in lower UPEC titers in the bladders of
C57Bl/6J mice at 48 hpi, despite reduced neutrophil infiltration
into the bladder [33]. Similarly, treatment with G-CSF exacer-
bates disease in a murine model of Klebsiella pneumoniae respiratory
tract infection [65]. Further studies are needed to identify the
immune cell populations required for the development of chronic
cystitis, and to clarify the role of these early innate responses in
disease pathogenesis.
We have found a strong association between elevated serum IL-
5 at 24 hpi and the development of chronic cystitis. IL-5 promotes
eosinophil and B1 lymphocyte development and IgA class
switching and has been reported to enhance production of IL-6
in kidney cell lines [66,67]. However, the role of IL-5 in UTI
pathogenesis is unclear. While ‘‘low level’’ IL-5 mRNA expression
has been reported in the mouse bladder early in UPEC infection of
C3H/HeN mice, IL-5 has not otherwise been implicated in UTI
pathogenesis [68]. T helper cells polarized to produce type 2
cytokines (TH2 cells) have long been considered the primary
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infection in this study was still present in C3Hscid mice. This
finding is consistent with a previous study in mice, which found
that non-lymphoid cells, such as mast cells or basophils, are the
major source of IL-5 in the peripheral organs [69]. Activation of
either of these cell types could mediate the bladder edema seen in
C3Hscid mice. However, if IL-5 is originating from the bladder, it
does not appear to be able to access the bladder lumen as IL-5 was
not elevated in the urines of mice at 24 hpi, regardless of disease
outcome.
C3H background mice are known to have differing susceptibil-
ities to various bacterial infections [70,71,72,73]. Currently, the
specific genetic basis for susceptibility to chronic cystitis and
chronic pyelonephritis are unknown. However, a recent mouse
genetics study by Hopkins and colleagues has made significant
progress in identifying genetic loci associated with susceptibility to
cystitis and pyelonephritis at 10 dpi in second generation crosses of
C3H/HeJ (reported as susceptible to each) and Balb/c (resistant)
mice [74]. In those studies, the authors utilized quantitative trait
loci (QTL) analyses to discover that the genetic basis for chronic
cystitis and pyelonephritis differed. This is consistent with our data
comparing experimental UPEC infection in the various C3H sub-
strains through 4 wpi, which demonstrate that chronic cystitis and
chronic pyelonephritis can be independent disease outcomes. In
C3H/HeN, C3H/HeSnJ, and C3HeB/FeJ mice with chronic
cystitis, concurrent kidney infection was an inconsistent finding
and, when present, was largely limited to the renal pelvis (pyelitis).
Equally, the majority of C3H/HeJ mice with chronic pyelone-
phritis did not have cystitis at sacrifice, as defined by the presence
of bladder inflammation and bacterial titers greater than 10
4 cfu.
Only in C3H/HeOuJ mice was there a strong association between
chronic cystitis and pyelonephritis.
Since previous work had demonstrated that UPEC infection of
both C3H/HeJ and C3H/HeOuJ mice resulted in similarly high
bladder titers at 14 dpi, it had been hypothesized that chronic
cystitis occurred independently of TLR4 signaling [45,50].
However, our studies have now demonstrated that these two
strains differ in their susceptibility to chronic cystitis. We suggest
that differences in experimental methodology, including the use of
ten-fold higher inocula and study durations limited to 2 weeks,
likely prevented resolution of the differing susceptibilities of C3H/
HeOuJ and C3H/HeJ mice to chronic cystitis in previous studies
[45,50]. In support of the hypothesis that enhanced TLR4
signaling contributes to the development of chronic cystitis, which
in turn enhances host susceptibility to recurrent symptomatic
infection, a TLR4 polymorphism that results in diminished
responses to LPS has recently been associated with reduced
susceptibility to rUTI in humans [75]. We also found that a subset
of C3H/HeJ mice developed a persistent biofilm-like bladder
colonization in the absence of robust inflammation. Bacterial
biofilms and reduced TLR4 expression on neutrophils have each
been associated with asymptomatic bacteriuria in humans [40,76].
Thus, the innate host responses in the urinary tract must be fine-
tuned to successfully eliminate UPEC infection while also
maintaining tissue integrity.
Intracellular bacterial communities (IBC) had not been
previously observed during the chronic stage of UTI and thus
their role in bacterial persistence was unknown. However, IBC
formation is known to be required during the acute stages of
infection [17,23,24,25,26,27,28,29] which is a prerequisite for
subsequent chronic infection. For example, we recently
identified residues in FimH, the mannose-binding tip adhesin
subunit of type 1 pili, that are under positive selection in UPEC
strains isolated from human patients with UTI and that function
in IBC formation [26]. A double mutation in two of these
residues abolished IBC formation despite retaining the ability to
bind to mannose, bind to the urothelium, and invade the
urothelium. This mutant was severely defective in a mouse
model of UTI, and behaved similarly to a fimH knockout or a
FimH receptor binding mutant. Therefore, this mutant
separated the phenotypes of (i) mannose-inhibitable binding
and invasion of the urothelium and (ii) IBC formation [26]. Its
phenotype in a mouse model of UTI indicates that both of these
phenotypes are critical for acute stages of UTI, which we have
now shown are a prerequisite for persistence. However, the lack
of development of chronic cystitis in C3Hscid mice and in C3H
mice treated with dexamethasone was not due to the lack of IBC
formation in the acute stages of infection since IBCs developed
normally in the acute stages of infection in these mice.
Furthermore, we found evidence of IBC formation in the
chronic stage of infection in C3H/HeJ mice, which have muted
inflammatory responses to UPEC infection. This finding
implicates mucosal inflammation, including urothelial reactivity
and exfoliation, in restrictingc o n t i n u o u sI B Cf o r m a t i o ni n
immunocompetent mice. It also raises the hypothesis that one
mechanism of asymptomatic bacteriuria, for which UPEC
infection of C3H/HeJ mice has been proposed as a model
[77], may be continuous IBC formation in hosts with muted
urothelial inflammatory responses to UPEC.
In summary, we have discovered a new basis for understanding
UTI that provides a possible mechanism for both chronic and
recurrent infection. We propose that, in females that are
genetically predisposed to enhanced mucosal TLR4 signaling,
initial episodes of UTI due to UPEC or Klebsiella pneumoniae may
be particularly severe in both degree of symptomatology and
duration. If allowed to progress past the early acute stage before
initiation of antibiotic therapy, these individuals could then
develop altered bladder mucosal responses to gram-negative
uropathogens. Upon repeated exposure to gram-negative uro-
pathogens, these individuals would then be at increased risk for
developing severe, symptomatic rUTI. It is also possible that a
quiescent intracellular reservoir (QIR) state may exist in humans,
similar to what has been described in mice [47,49], not only
serving as seeds for recurrent UTI, but also potentially
modulating the mucosal response to UPEC due to the chronic
persistence of bacteria within mucosal cells. This hypothetical
model not only provides a logical basis for further, intensive
murine and human UTI studies, but also extends our general
understanding of chronic and recurrent gram-negative infections
of mucosae.
Materials and Methods
Ethics statement
All animal experimentation was conducted following the
National Institutes of Health guidelines for housing and care of
laboratory animals and performed in accordance with institutional
regulations after pertinent review and approval by the Animal
Studies Committee at Washington University School of Medicine.
Bacterial strains and cultivation
The UPEC strains used in this study were the human cystitis
isolate, UTI89 [17] and derivatives thereof: UTI89 attHK022::COM-
GFP (kanamycin-resistant, Kan
R) and UTI89 attl::PSSH10-1
(spectinomycin-resistant, Spc
R) [78]; and the human pyelonephri-
tis isolate, J96 [79]. The Klebsiella pneumoniae strain used, TOP52, is
a human cystitis isolate [29]. Bacteria were routinely cultured in
Luria-Bertani (LB) broth.
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C3H/HeN mice were obtained from Harlan Sprague Dawley,
Inc. (Indianapolis, IN). 129S1/SvImJ, Balb/cJ, C3HeB/FeJ,
C3H/HeJ, C3H/HeOuJ, C3H/HeSnJ, C3Smn.CB17-Prkdc
scid/J,
C57BL/6J, CBA/J and DBA/2J mice were all obtained from the
Jackson Laboratory (Bar Harbor, ME). Bacterial strains were
inoculated into 20 mL of LB broth directly from freezer stock,
grown statically at 37uC overnight, and subcultured 1:1000 into
20 ml of fresh media and again grown statically at 37uC for 18 hr.
These cultures were centrifuged for 10 min at 30006g, resus-
pended in 10 ml PBS, and then diluted to approximately 2–
4610
8colony forming units (cfu)/ml (OD600=0.35). 50mL of this
suspension (,1–2610
7 cfu) or one concentrated 10-fold (,1–
2610
8 cfu) was inoculated into the bladders of 7–8 week old
female mice by transurethral catheterization.
Urine collection, bacterial titering, and urine sediment
analysis
In most cases urines were collected prior to infection, at 1, 3, 7,
10, and 14 dpi, and then weekly thereafter by applying suprapubic
pressure with proper restraint and collecting the urine stream in
sterile 1.5ml eppendorf tubes. Urines were then serially diluted in
PBS and 50 mL total of each dilution was spotted onto LB, and LB
with 25 mg/ml kanamycin (LB/Kan25) where appropriate. In
experiments where a marked strain was used, urine titers were
always reported from the plate containing the relevant antibiotic.
Urine sediments were obtained by cytocentrifuging 80 mLo fa
1:10 dilution of the collected urine onto poly-L-lysine-coated glass
slides and stained as described [28]. Stained urine sediments were
examined by light microscopy on an Olympus BX51 light
microscope (Olympus America), and the average number of
polymorphonuclear leukocytes (PMN) per 4006 magnification
field (hpf) calculated from counting 5 fields. A semi-quantitative
scoring sytem was created to facilitate analysis: 0, less than 1
PMN/hpf; 1, 1–5 PMN/hpf; 2, 6–10 PMN/hpf; 3, 11–20 PMN/
hpf, and 4, .20 PMN/hpf.
Tissue bacterial titer determinations
To quantify the bacteria present in urinary tract tissues at the
time of sacrifice, bladders and kidneys were aseptically harvested
at the indicated time point and homogenized in PBS. Homoge-
nates were then serially diluted and spotted as described above,
duplicate plating on LB and LB/Kan25 where appropriate. Tissue
homogenates to be analyzed later for the presence of soluble
cytokines were centrifuged at high speed for 59 at 4uC and the
supernatant removed for storage at 280uC.
Serum collection and storage
Venous blood was collected by submandibular puncture using
5 mm steel lancets (Medipoint, Inc., Mineola, NY) into BD
Microtainer serum separation 400 ml tubes. Blood tubes were
allowed to clot at room temperature for 1–2 hours and, after
centrifugation at 15,0006g for 59, were stored at 220uC.
Histopathology and immunofluorescence
Tissues were either fixed in methacarn (60% methanol, 30%
chloroform, 10% glacial acetic acid) or embedded in OCT and
frozen on dry ice before long term storage at 280uC. Methacarn
fixed tissues were embedded in paraffin, sectioned, and stained
with hemotoxylin and eosin. Bladder inflammatory scores were
determined in a blinded fashion by two investigators (T.J.H. and
C.S.H.) and an average score calculated, as previously described
[45]. 7mm thick frozen sections were cut and fixed in acetone at
220uC for 10 minutes. All sections were hydrated and blocked in
1% BSA, 0.3% triton X-100 in PBS. After incubation with
primary and secondary antibodies and associated washes, slides
were stained with bis-benzimide (Sigma). Stained tissues were
examined by epifluorescence microscopy on a ZEISS Axioskop 2
MOT Plus microscope.
Serum and urine cytokine analysis
The presence of 23 mouse cytokines was analyzed in specimens
by a Luminex-based multiplex cytometric bead array platform
(Bioplex, Bio-Rad, Hercules, CA). These cytokines were IL-1a, IL-
1b, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (p40 subunit),
IL-12 (p70 subunit), IL-13, IL-17, Eotaxin, G-CSF, granulocyte-
macrophage colony-stimulating factor (GM-CSF), gamma inter-
feron, KC, monocyte chemotactic protein 1 (MCP-1), macro-
phage inflammatory protein (MIP) 1a, MIP-1b, Regulated upon
Activation, Normal T-cell Expressed and Secreted (RANTES),
and tumor necrosis factor a. Individual samples were run in
duplicate and the mean values used in all graphs.
Glucocorticoid treatment
Dexamethasone sodium phosphate (Dexaject SP, Butler Animal
Health Supply, Dublin, OH) was diluted to 1 mg/ml in sterile
saline and one group of mice were given 200 uL of this solution
intraperitoneally (i.p.), corresponding to a dose of 20 mg (10 mg/
kg), two hours prior to UPEC infection, as previously described
[80,81]. Another group of control mice were mock-treated i.p.
with sterile saline alone.
UPEC challenge infections
At 1, 14, or 28 dpi with either PBS or 10
8 cfu of Kan
R, all mice
were treated with trimethoprim and sulfamethoxazole in the
drinking water daily for 10 days at concentrations of 54 and
270 mg/ml, respectively [46]. During this time, longitudinal
urinalysis was continued weekly to confirm clearance of bacteri-
uria. Four weeks after the initiation of antibiotic therapy, mice
from each test group (previously infected or naı ¨ve) were challenged
with either PBS or 10
7 cfu of UTI89 Spc
R. Longitudinal urinalysis
was then performed as for the primary infection (except now
triplicate plating on LB, LB/Kan25 and McConkey agar with
50 mg/ml spectinomycin (McC/Spc50) to identify mice with
persistent bacteriuria and the responsible strain. Mice were
sacrificed 4 weeks after challenge and tissue titers determined as
above, triplicate plating on LB, LB/Kan25, and LB/Spc50.
Statistical analysis
Statistical analyses were performed using GraphPad Prism and
InStat (GraphPad Software) and significance was defined by
attaining P values,0.05, in two-tailed tests where appropriate.
UniProt accession numbers for proteins mentioned in the
text
Mouse Interleukin 5: P04401; Mouse Interleukin 6: P08505;
Mouse Granulocyte Colony Stimulating Factor: P09920; Mouse
Keratinocyte-derived Cytokine (Growth-regulated alpha protein):
P12850.
Supporting Information
Figure S1 Numerous C3H and related inbred mouse strains are
susceptible to chronic cystitis with the UPEC strain, UTI89. Time
course of bacteriuria and tissue titers were assayed after 4 weeks of
infection with 10
7 or 10
8 cfu of either UTI89 Kan
R or UTI89 as
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and D,DBA/2Jmice.Solidlinesconnecttheurinetitersovertimefor
each individual mouse. Dashed horizontal lines in time courses
represent the cutoff for significant bacteriuria in free catch urines: 10
4
cfu/ml. Tissue titer plots depict urine (U), bladder (B)a n dk i d n e y( K)
titers of individual mice at 4 wpi, grouped by outcome of longitudinal
urinalysis: resolved bacteriuria (R) or persistent bacteriuria (PB). Solid
lines connect the different urine and tissue titers from the same
mouse. Dotted horizontallines in tissue titer plotsindicate the limitsof
detection. Data are combined from at least two independent
experiments for each inbred mouse strain.
Found at: doi:10.1371/journal.ppat.1001042.s001 (0.67 MB
DOC)
Figure S2 BALB/cJ and 129S1 mice are resistant to chronic
cystitis with the UPEC strain, UTI89. Time course of bacteriuria
and tissue titers were assayed after 4 weeks of infection with 10
7 or
10
8 cfu of either UTI89 Kan
R or UTI89 as indicated in Table 1,
in A, BALB/cJ and B, 129S1/SvImJ mice. Solid lines connect the
urine titers over time for each individual mouse. Dashed
horizontal lines in time courses represent the cutoff for significant
bacteriuria in free catch urines: 10
4 cfu/ml. Tissue titer plots
depict urine (U), bladder (B) and kidney (K) titers of individual
mice at 4 wpi, grouped by outcome of longitudinal urinalysis:
resolved bacteriuria (R) or persistent bacteriuria (PB). Solid lines
connect the different urine and tissue titers from the same mouse.
Dotted horizontal lines in tissue titer plots indicate the limits of
detection. Data are combined from two independent experiments
for each inbred mouse strain, except for BALB/cJ mice infected
with 10
7 cfu, which is from a single experiment.
Found at: doi:10.1371/journal.ppat.1001042.s002 (0.28 MB
DOC)
Figure S3 Chronic cystitis in C3H/HeN mice is not restricted to
infection with UTI89. Time course of bacteriuria and tissue titers in
C3H/HeN mice were assayed after 4 weeks of infection with either
10
7 or 10
8 cfu of A,J 9 6 ,ah u m a nU P E Ci s o l a t e ,o rB, Top52, a
Klebsiella pneumonia strain isolated from a woman with cystitis. Solid
lines connect the urine titers over time for each individual mouse.
Dashed horizontal lines in time courses represent the cutoff for
significant bacteriuria in free catch urines: 10
4 cfu/ml. Tissue titer
plots depict urine (U), bladder (B)a n dk i d n e y( K) titers of individual
miceat4wpi,groupedbyoutcomeoflongitudinalurinalysis:resolved
bacteriuria (R) or persistent bacteriuria (PB). Solid lines connect the
different urine and tissue titers from the same mouse. Dotted
horizontal lines in tissue titer plots indicate the limits of detection.
Data in panel A are combined from two independent experiments
and the data from panel B are from a single experiment.
Found at: doi:10.1371/journal.ppat.1001042.s003 (0.28 MB
DOC)
Figure S4 Parameters of severe acute inflammation at 24 hpi are
predictive of persistent bacteriuria with UPEC in C3H/HeOuJ,
but not C3H/HeJ, mice. C3H/HeOuJ (closed circles) and C3H/
HeJ (open circles) mice were infected with 10
7 cfu UTI89 Kan
R
and assessed at 24 hpi for A, pyuria, B, weight loss and C, serum
cytokine levels. Mice were grouped by the outcome of longitudinal
urinalysis over 4 wpi, i.e. whether they resolved bacteriuria (R),
were persistently bacteriuric (PB), or in the case of C3H/HeJ mice
whether they died during the course of infection (D). Data are
combined from two independent experiments. All statistics are by
Mann-Whitney U two-tailed test: *, P,0.05, **, P,0.01, ***,
P,0.001 and ns, not significant; horizontal bars indicate median
values.
Found at: doi:10.1371/journal.ppat.1001042.s004 (0.27 MB
DOC)
Figure S5 Serum cytokines are also predictive of the develop-
ment of chronic cystitis in C3H/HeN mice after infection with the
UPEC strain, J96. C3H/HeN mice were infected with either 10
7
or 10
8 cfu of the UPEC strain J96 and sera were collected at 24 hpi
for cytokine analysis. Mice were grouped by the outcome of
longitudinal urinalysis over 4 wpi, i.e. whether they resolved
bacteriuria (R) or were persistently bacteriuric (PB). Data from
both inoculums in two independent experiments are combined in
the analysis. All statistics are by Mann-Whitney U two-tailed test:
*, P,0.05; horizontal bars indicate median values.
Found at: doi:10.1371/journal.ppat.1001042.s005 (0.30 MB
DOC)
Figure S6 Urine cytokines are also predictive of the develop-
ment of chronic cystitis. C3H/HeN mice were infected with 10
7
cfu UTI89 Kan
R and urines were collected at 24 hpi for cytokine
analysis. Mice were grouped by the outcome of longitudinal
urinalysis over 4 wpi, i.e. whether they resolved bacteriuria (R)o r
were persistently bacteriuric (PB), with a PBS-infected group
(Mock) as controls. Data from two independent experiments are
combined in the analysis. One outlier mouse from the resolved
group was excluded from the analysis because she had a renal
abscess, an outcome not previously observed in C3H/HeN mice.
All statistics are by Mann-Whitney U two-tailed test: *, P,0.05,
**, P,0.01 and ns, not significant with P.0.10 unless otherwise
indicated; horizontal bars indicate median values.
Found at: doi:10.1371/journal.ppat.1001042.s006 (0.32 MB
DOC)
Figure S7 C3Hscid mice resolved UPEC infection more readily
than their congenic strain, C3H/HeSnJ, and have less acute
weight loss during acute infection. C3H/HeSnJ (closed circles) and
C3Smn.CB17-Prkdc
scid/J (open circles) mice were infected with 10
8
cfu of either UTI89 Kan
R or UTI89. Data are combined from 4
independent experiments. A, The time course of bacteriuria over 4
wpi was determined by longitudinal urinalysis. Solid lines connect
the urine titers over time for each individual mouse. Horizontal
dashed lines represent the cutoff for significant bacteriuria in free
catch urines: 10
4 cfu/ml. B, Acute weight loss was assessed at 24
hpi. Statistics are by Mann-Whitney U two-tailed test: ***,
P,0.001; horizontal bars indicate median values.
Found at: doi:10.1371/journal.ppat.1001042.s007 (0.36 MB
DOC)
Figure S8 Dexamethasone pre-treatment of C3H/HeN mice
protects against chronic infection, despite similar bladder bacterial
burdens at 24 hpi. C3H/HeN mice were infected with 10
8 cfu
UTI89 Kan
R 2 hours after pre-treatment by intraperitoneal
injection with either 200ug dexamethasone sodium phosphate
(open circles) diluted in sterile saline or sterile saline alone (closed
circles). A, the time course of bacteriuria over 4 wpi was
determined by longitudinal urinalysis and the data from three
independent experiments combined. Solid lines connect the urine
titers over time for each individual mouse. Horizontal dashed lines
represent the cutoff for significant bacteriuria in free catch urines:
10
4 cfu/ml. B, mice were sacrificed at 24 hpi and bladder bacterial
burdens assayed. Statistics are by Mann-Whitney U two-tailed
test: ns, not significant; horizontal bars indicate median values.
Found at: doi:10.1371/journal.ppat.1001042.s008 (0.27 MB
DOC)
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